NCT07077824 Effect of Stellate Ganglion Block on Arterial Catheterization Complications in Selected Group of Patients Undergoing Elective Cardiac Surgeries
| NCT ID | NCT07077824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Cardiac Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2026-01-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-15 with a primary completion date of 2026-01-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Radial artery catheterization is the usual method for invasive monitoring in cardiac surgeries. Although it is relatively safe, complications do happen. Hematoma and ischemia are well known complications. Also, radial-to-femoral arterial pressure gradient (RFAPG) post bypass is a common event which affect management of a critical patient in a critical time. the study examines the effect of left stellate ganglion block (LSGB) on decreasing radial artery complications in cardiac surgeries
Eligibility Criteria
Inclusion Criteria: * • Multiple procedures with expected prolonged bypass time (\>100 min) * EF\< 35% * Moderate or severe Pulmonary hypertension Exclusion Criteria: * • Patient not willing to participate in the study. * History of strokes / Transient ischaemic attacks * History of Glaucoma. * History of allergy to local anaesthetic drugs. * Pre-existing contralateral phrenic nerve palsy. * Patients with existing coagulopathy. * BMI \>35
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07077824 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07077824 currently recruiting?
Yes, NCT07077824 is actively recruiting participants. Contact the research team at Dr.soudi2014@med.asu.edu.eg for enrollment information.
Where is the NCT07077824 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07077824 clinical trial?
NCT07077824 is sponsored by Ain Shams University. The trial plans to enroll 40 participants.